ALEC株価 $1.52 · 時価総額 $168m
Alector, Inc.
Biological Products, (No Diagnostic Substances)| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $97m | $101m | $21m |
| 成長率 | — | 3.6% | -79.1% |
| 総利益 | — | — | — |
| 総利益率 | — | — | — |
| 販管費 | $57m | $60m | $54m |
| 販管費率 | 58.4% | 59.3% | 256.5% |
| 営利 | $-152m | $-145m | $-156m |
| 営利率 | -156.3% | -144.2% | -741.3% |
| 純利益 | $-130m | $-119m | $-143m |
| PSR | 1.73x | 1.67x | 7.97x |
| PGPR | — | — | — |
| PER | — | — | — |
| PBR | 1.25x | 1.32x | 5.47x |
| ネットキャッシュ | $75m | $24m | $56m |
| EV/EBITDA | — | — | — |
| Rule of 40 | — | -140.6% | -820.4% |
| セールス効率 | — | — | — |
※Rule of 40は売上成長率+営業利益率、セールス効率は売上総利益増加÷販管費増加(販管費増のときのみ)
